Search hospitals > Wisconsin > Milwaukee
Children's Hospital of Wisconsin
Claim this profileMilwaukee, Wisconsin 53226
Global Leader in Leukemia
Global Leader in Tumors
Conducts research for Recurrence
Conducts research for Lymphoma
Conducts research for Brain Tumor
414 reported clinical trials
26 medical researchers
Summary
Children's Hospital of Wisconsin is a medical facility located in Milwaukee, Wisconsin. This center is recognized for care of Leukemia, Tumors, Recurrence, Lymphoma, Brain Tumor and other specialties. Children's Hospital of Wisconsin is involved with conducting 414 clinical trials across 645 conditions. There are 26 research doctors associated with this hospital, such as Paul D. Harker-Murray, Meghen B. Browning, Michael Burke, MD, and Peter H. Shaw.Area of expertise
1Leukemia
Global LeaderStage IV
Philadelphia chromosome positive
Stage II
2Tumors
Global LeaderStage IV
Stage I
Stage II
Top PIs
Paul D. Harker-MurrayChildren's Hospital of Wisconsin7 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
19 reported clinical trials
26 drugs studied
Meghen B. BrowningChildren's Hospital of Wisconsin18 years of reported clinical research
Studies Tumors
Studies Neuroblastoma
16 reported clinical trials
40 drugs studied
Michael Burke, MDChildren's Hospital of Wisconsin1 year of reported clinical research
Expert in Leukemia
Studies Acute Lymphoblastic Leukemia
14 reported clinical trials
43 drugs studied
Peter H. ShawJohns Hopkins All Children's Hospital4 years of reported clinical research
Studies Leukemia
Studies Hodgkin's Lymphoma
9 reported clinical trials
35 drugs studied
Clinical Trials running at Children's Hospital of Wisconsin
Brain Tumor
Acute Lymphoblastic Leukemia
Osteosarcoma
Germ Cell Tumors
Rhabdoid Tumor
Non-Hodgkin's Lymphoma
Leukemia
Tumors
Astrocytoma
Cancer
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Selumetinib vs Carboplatin/Vincristine
for Brain Cancer
This phase III trial studies if selumetinib works just as well as the standard treatment with carboplatin/vincristine (CV) for subjects with NF1-associated low grade glioma (LGG), and to see if selumetinib is better than CV in improving vision in subjects with LGG of the optic pathway (vision nerves). Selumetinib is a drug that works by blocking some enzymes that low-grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether selumetinib works better in treating patients with NF1-associated low-grade glioma compared to standard therapy with carboplatin and vincristine.
Recruiting2 awards Phase 328 criteria
Selumetinib + Vinblastine
for Low-Grade Glioma
This phase III trial investigates the best dose of vinblastine in combination with selumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinib alone in treating children and young adults with low-grade glioma (a common type of brain cancer) that has come back after prior treatment (recurrent) or does not respond to therapy (progressive). Selumetinib is a drug that works by blocking a protein that lets tumor cells grow without stopping. Vinblastine blocks cell growth by stopping cell division and may kill cancer cells. Giving selumetinib in combination with vinblastine may work better than selumetinib alone in treating recurrent or progressive low-grade glioma.
Recruiting2 awards Phase 339 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Children's Hospital of Wisconsin?
Children's Hospital of Wisconsin is a medical facility located in Milwaukee, Wisconsin. This center is recognized for care of Leukemia, Tumors, Recurrence, Lymphoma, Brain Tumor and other specialties. Children's Hospital of Wisconsin is involved with conducting 414 clinical trials across 645 conditions. There are 26 research doctors associated with this hospital, such as Paul D. Harker-Murray, Meghen B. Browning, Michael Burke, MD, and Peter H. Shaw.
Where is Children's Hospital of Wisconsin located?
**Children's Hospital of Wisconsin**
- **Address:** 8915 W Connell Ct, Milwaukee, WI 53226
- **Directions:** From I-94 W, take exit 309B for 84th St towards Wauwatosa. Turn right onto W North Ave, then left onto N 84th St. After 0.5 miles, turn right onto W Connell Ave. The hospital is on your left.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Children's Hospital of Wisconsin, contact them at (414) 266-6262 or via email at FinancialAssistance@childrenswi.org. For insurance inquiries, reach out to their main switchboard at (414) 266-2000 or toll-free at (877) 266-8989. Their mailing address is 8915 W. Connell Ct. P.O. Box 1997, Milwaukee, WI 53226.
What insurance does Children's Hospital of Wisconsin accept?
Children's Hospital of Wisconsin accepts a wide range of insurance plans, ensuring access to high-quality healthcare for its patients. Among these, Chorus Community Health Plans (CCHP), an affiliate of Children's Wisconsin, offers BadgerCare Plus in 28 counties and Individual and Family Plans across 15 counties in eastern Wisconsin. Additionally, the hospital is in-network with numerous other insurers, including but not limited to Aetna, Anthem Wisconsin, Cigna Health Plan, Humana, Medicaid Wisconsin, Medicare, and UnitedHealthcare.
What awards or recognition has Children's Hospital of Wisconsin received?
Children's Hospital of Wisconsin in Milwaukee is renowned for its outstanding patient care, employer practices, and community partnerships. It has also been recognized for its significant contributions to pediatric science through its nursing research and evidence-based practice department. This department has developed a support network for pediatric nurse scientists, fostering nurse-led, collaborative research across various disciplines and sites.